Celldex Therapeutics | CLDX - Ebit

Preço das Ações
33.89
Mudança Diária
0.03 0.09%
Mensal
8.10%
Anual
79.22%
Q2 Previsão
31.64




Ebit Alterar Data
AbbVie USD 4.73B 1.08B 2026-03
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.83B 130M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Celldex Therapeutics USD -87.15M 13.54M 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Northwest Biotherapeutics USD -14.32M 822K 2025-09
Pfizer USD 4.99B 340M 2026-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 9.56B 2.1B 2025-12